As the above formula is constructed for calculation of total alcohol-related burden, a modified formula has been applied in order to calculate an AAF for each consumption group: Using the modified formula normally results in an increased number of alcohol-related episodes, compared to the original formula.
An additional analysis with the original formula in our data provided a relatively high prevalence similar to results of that study [ 23]; however, we believe that the estimated prevalence derived from the modified formula is appropriate.
In this paper, we study the modified formula of [43] and obtain global convergence and superlinear convergence under generally convex conditions.
In particular, if β n = 0 ∀n, the modified formula generally reduces to the Mann formula and then the example of Chidume and Mutangadura [21] shows that the modified formula will not converge to a fixed point of T in the setting of Theorem IS (see, e.g., [8] for more comments on the Ishikawa iteration formula).
The inaccuracy in the modified formulae may be due in part to the differences in the calibration of SC assays.
The modified formula disallows consecutive insertions and deletions, as is done in Probalign and MSAProbs.
Performances of the modified formulae were assessed in terms of four factors – bias, precision, accuracy, and GFR category misclassification rate.
In each group, one type of material parameter is selected as the base material and the corresponding strength curve is expressed in the form of a modified Perry formula that serves as the base strength curve.
A novel approach is presented, based on the integral form of the vorticity formulation, in which the vorticity transport equation is solved by using the cell-centred finite-volume method, while the velocities needed at the centre of each control volume are calculated by a modified Biot Savart formula in conjunction with a fast summation algorithm.
The performances of the six modified formulae in various GFR categories were analyzed.
Our findings suggest that all six modified formulae developed in Asian populations may show great bias in elderly Chinese patients with CKD.
